remdesivir covid-19 liquid medication background

NIH Launches Remdesivir Plus Interferon Beta-1a Trial for COVID-19 Treatment

The study, called the Adaptive COVID-19 Treatment Trial 3 (ACTT 3), is anticipated to enroll more than 1,000 hospitalized adults with COVID-19 at as many as 100 sites in the United States and abroad.
Gut bacteria , gut flora, microbiome. Bacteria inside the small intestine, concept, representation. 3D illustration.

The Gut Microbiome Helps Determine B Cell and Antibody Repertoire

Custom computer programs processed millions of genetic sequences to compare the antibody repertoire from B cells, depending on whether the microbes stay in the intestine, or whether they reach the bloodstream. In both cases, the antibody repertoire is altered, but in rather different ways depending on how the exposure occurs.
Tumor profiling assays of Foundation Medicine and Caris Life Sciences will identify abnormalities qualifying a patient for personalized cancer treatment through NCI-MATCH. [Royalty Stock Photo/Shutterstock]

TRACK Study Seeks to Develop Precision Medicine Approaches for Rare Cancers

TRACK will recruit 400 people diagnosed with any rare cancer, which is defined as incidence of six per 100,000 people, per year, in the U.S. The study will focus on cholangiocarcinoma and cancer of unknown primary due to the promise of precision approaches in these subsets.
Freenome’s artificial intelligence (AI) genomics platform

AI Predicts Patient Phenotypes that Will Develop Drug Resistance

Findings from the new study could point to methods for identifying diseases and predicting their behaviors that are faster, simpler, less expensive, and more accurate than current standard techniques.

Gene Expression Signature in Blood Can Diagnose Brain Damage in Newborn Babies

Results from the early blood tests showed that those that had poor outcomes from oxygen deprivation during birth could be predicted based on changes in the expression of 855 genes in the blood shortly after birth.
Glioma - brain tumor

Researchers Begin to Unravel Glioma Chemoresistance

Research from the Spanish National Cancer Research Center (CNIO) and the Hong Kong University of Science and Technology (HKUST) shows that a subset of patients acquires a specific genetic alteration that can evade treatment from a combination of chemotherapy and radiotherapy.
Intestinal microbiome, medical concept

Gut Microbiome Can Trigger Sickle Cell Disease Complications

Using vaso-occlusive episodes (VOEs) of sickle cell disease (SCD) as a vascular disease model, researchers at Albert Einstein College of Medicine discovered that the gut plays a critical role in provoking episodes of VOEs.
Coronavirus, artwork

Oxford Nanopore to Supply U.K. with 450K LamPORE COVID-19 Tests

LamPORE uses Oxford Nanopore’s sequencing technology to precisely identify amplified sections of the SARS-CoV-2 virus, after it has been targeted and amplified using RT-LAMP, which can differentiate between actual SARS-CoV2 presence and errors that can occur during amplification.
Skin cancer, light micrograph

Low Amounts of ctDNA Can Predict Good Immunotherapy Outcome

Cancer patients who have low levels of circulating tumor (ct)DNA before starting treatment with immunotherapy are more likely to have a positive response to the treatment, according to research from the University of Toronto.

PacBio, Asuragen Collaborate on Carrier Screening Test Development

Asuragen will leverage its AmplideX PCR technology for enriching hard-to-amplify sequences with PacBio SMRT Sequencing to develop tests to be run on PacBio’s Sequel Systems.
Scroll Up